NBP — NovaBridge Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for NovaBridge Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	fx Final	fx Final	fx Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	734	673	500	312	173
Net Total Accounts Receivable
Net Total Receivables	67.9	59.3	1.19	1.79	1.04
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	819	753	526	330	177
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.17	25	18	5.55	3.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	971	882	591	369	213
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	88.3	98.2	110	58.1	8.45
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	108	164	169	126	11.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	862	718	422	243	201
Total Liabilities & Shareholders' Equity	971	882	591	369	213
Total Common Shares Outstanding